CytoSorbents Corporation (CTSO)

[hemopure36]

I can't make heads or tails of what you just wrote. I agree that $80 million/year is the capacity, and I haven't heard anyone dispute that. The backlog issue has been explained, and whether you liked the explanation or not, it was the only explanation we got and we have to move forward, despite your incessantly wanting to move backward and plant doubts. However, this has nothing to do with my previous post. It has to do with your trying to set unreasonably high expectations for FDA guidance regarding Ticagrelor approval. By far, the odds favor the FDA requiring a trial for Ticagrelor removal. However, you've placed that in a "we're screwed" scenario, which is disingenuous at best. Everyone assumed we'd need a trial until Techxen pointed out that Dr. Chan uttered the word, "if" we need a trial. You grabbed onto that and now make it your baseline case and anything other than that is now part of a "we're screwed" scenario. I don't think you're ignorant, so the only other options for your trying to sow all kinds of negative seeds is that you're actively disingenuous in your postings, which seem to be at odds with someone who holds the stock long.

What you're misunderstanding, it seems, it my point about FDA guidance vis a vis Ticagrelor removal, NOT the manufacturing capacity. That's a diversion that you keep using to avoid addressing my points.